Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLH-2004
2005-003279-18Phase 4
- Sponsor
- Childhood Cancer Research Unit, Astrid Lindgren Children's Hospital
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etoposide, dexamethasone, cyclosporine, methotrexate and prednisolone in haemophagocytic lymphohistiocytosis (HLH), sponsored by Childhood Cancer Research Unit, Astrid Lindgren Children's Hospital. Primary endpoints: Survival before stem cell transplantation, Total survival and 1 more.
02
Drugs
etoposidedexamethasonecyclosporinemethotrexateprednisolone
03
Conditions
haemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on 2005-003279-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003279-18.